Yonghui Wang

15PUBLICATIONS
11CO-AUTHORS
Biologically active moleculesMolecular targetsMedical molecular engineering of nucleic acids and proteinsAutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 14, 2024
Subtle Structural Changes across the Boundary between A2AR/A2BR Dual Antagonism and A2BR Antagonism: A Novel Class of 2-Aminopyrimidine-Based Derivatives.

Haojie Wang, Xinyu Yang, Yan Li

|Nov 20, 2023
Discovery of Biaryl Amide Derivatives as Potent, Selective, and Orally Bioavailable RORγt Agonists for Cancer Immunotherapy.

Lixue Lu, Yafei Huang, Meiqi Song

|Mar 23, 2023
Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A2A Receptor Antagonists for Cancer Immunotherapy.

Chenyu Zhu, Shuyin Ze, Ronghui Zhou

|Jan 11, 2023
Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the β-Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the Treatment of Colorectal Cancer.

Hao Zhang, Chenglong Liu, Qiushi Chen

|Jul 15, 2022
Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer's Disease.

Kang Qian, Xiaoyan Bao, Yixian Li

|Feb 25, 2022
Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8H)-one Derivatives as Novel Potent Adenosine A2A Receptor Antagonists for Cancer Immunotherapy.

Fazhi Yu, Chenyu Zhu, Shuyin Ze

Pageof 3

Frequent Collaborators

4 joint publications

Weiqiang Lu

3 joint publications

Mingyao Liu

2 joint publications

Yan Li

1 joint publications

Wei Fu